Browsing by Subject "Thrombectomy"

Sort by: Order: Results:

Now showing items 1-7 of 7
  • Strbian, Daniel; Isokangas, Juha-Matti; Lindsberg, Perttu J. (2020)
  • Vanninen, Ritva; Putaala, Jukka; Bode, Michaela; Nyman, Mikko; Pekkola, Johanna; Manninen, Hannu (2016)
  • Mustanoja, Satu; Pekkola, Johanna (2016)
    Akuu­tin ai­vo­val­ti­mo­tu­kok­sen las­ki­mon­si­säis­tä liuo­tus­hoi­toa voi­daan an­taa nel­jän ja puo­len tun­nin ku­lues­sa oi­rei­den alus­ta. Hoi­to on aloi­tet­ta­va he­ti, kun vas­ta-ai­heet on pois­sul­jet­tu. Jos po­ti­laan ai­vo­ve­ren­kier­to­häi­riön oi­reet ovat vai­keat, ei suu­ren ai­vo­val­ti­mon tu­kok­sen las­ki­mon­si­säi­nen liuo­tus­hoi­to yleen­sä rii­tä. Sen li­säk­si har­ki­taan en­do­vas­ku­laa­ri­hoi­to­na lä­hin­nä me­kaa­nis­ta trom­bek­to­miaa kuu­den tun­nin ku­lues­sa. En­do­vas­ku­laa­ri­hoi­toa har­ki­taan myös sil­loin, kun las­ki­mon­si­säi­sel­le liuo­tus­hoi­dol­le on vas­ta-ai­he: INR-ar­vo yli 1,7 tai po­ti­las käyt­tää sään­nöl­li­ses­ti uut­ta ve­re­no­hen­nus­lää­ket­tä da­bi­gat­raa­nia, ri­va­rok­sa­baa­nia tai ­apik­sa­baa­nia. Pää­tös en­do­vas­ku­laa­ri­hoi­don aloit­ta­mi­ses­ta teh­dään ylio­pis­to­sai­raa­las­sa mo­niam­ma­til­li­ses­ti, ja toi­men­pi­teen ai­hees­ta päät­tää neu­ro­lo­gi yh­des­sä sen suo­rit­ta­van ra­dio­lo­gin kans­sa. Hoi­dos­ta on an­net­tu uu­si oh­jeis­tus, jo­ka kos­kee neu­ro­lo­gian päi­vys­tä­jien li­säk­si myös päi­vys­tyk­sen eri­koi­sa­laa, ku­ten kes­kus­sai­raa­la­ta­soi­sia päi­vys­tä­jiä. Päi­vys­tyk­sel­li­seen AVH-hoi­toon lä­het­tä­mi­sen kri­tee­rit säi­ly­vät en­nal­laan ja hoi­don va­lin­taan ote­taan kan­taa ylio­pis­to­sai­raa­loi­den päi­vys­tys­pis­teis­sä.
  • Jonsson, Magnus; Aro, Ellinoora; Bjorses, Katarina; Holmin, Staffan; Ijäs, Petra; Martinez-Majander, Nicolas; Vikatmaa, Pirkka; Wahlgren, Carl-Magnus; Venermo, Maarit; Björck, Martin (2022)
    Objective: Recent randomised controlled trials demonstrated the benefit of intracranial endovascular thrombectomy (EVT) in acute ischaemic stroke. There is no consensus, however, on how to treat concomitant extracranial carotid artery stenosis after EVT. The aim of this study was to evaluate the outcome in patients treated with carotid endarterectomy (CEA) after EVT, comparing complication rates among patients undergoing CEA for stroke without previous EVT. Methods: This was a registry study of all patients (n = 3 780) treated with CEA after stroke in Sweden and the capital Helsinki region, Finland, from January 2011 to September 2020. Sixty three patients (1.7%; 0.5% 2011, 4.3% 2019) underwent EVT prior to CEA. The primary outcome was 30 day stroke and death rate. Results: The EVT+CEA group had major stroke as the qualifying neurological event (QNE) in 79%, but just 5.9% had this in the CEA only group (p < .001). Intravenous thrombolysis was administered before EVT in 54% of patients in the EVT+CEA group, but in just 12% in those receiving CEA only (p < .001). The combined stroke and death rate at 30 days for EVT+CEA was 0.0% (95% confidence interval [CI] 0.0 - 5.7). One patient had a post-operative TIA, none had post-operative intracerebral or surgical site haemorrhage. CEA was performed within a median of seven days (interquartile range 4, 15) after QNE, and 75% had CEA Conclusion: These results indicate that CEA is safe to perform after previous successful EVT for acute ischaemic stroke. Results were comparable with those undergoing CEA only, despite the EVT+CEA patients having more severe stroke symptoms prior to surgery, and timing was similar.
  • Tiainen, Marjaana; Martinez-Majander, Nicolas; Virtanen, Pekka; Räty, Silja; Strbian, Daniel (2022)
    Objectives: Data concerning the results of endovascular thrombectomy (EVT) in old patients is still limited. We aimed to investigate the outcomes in thrombectomytreated ischemic stroke patients aged > 80 years, focusing on frailty as a contributing factor. Patients and methods: We performed a single-centre retrospective cohort study with 159 consecutive patients aged > 80 years and treated with EVT for acute ischemic stroke between January 1st 2016 and December 31st 2019. Pre-admission frailty was assessed with the Clinical Frailty Scale (CFS). Patients with CFS > 5 were defined as frail. The main outcome was very poor outcome defined as mRS 46 at three months after EVT. Secondary outcomes were recanalization status, symptomatic intracerebral haemorrhage (sICH), and one-year survival. Finally, we recorded if the patient returned home within 12 months. Results: Very poor outcome was observed in 57.9% of all patients (52.4% in non-frail and 79.4% in frail patients). Rates of recanalization and sICH were comparable in frail and non-frail patients. Of all patients, 46.5% were able to live at home within 1 year after stroke. One-year survival was 59.1% (65.6% in non-frail and 35.3% in frail patients). In logistic regression analysis higher admission NIHSS, not performing thrombolysis, lack of recanalization and higher frailty status were all independently associated with very poor three-month outcome. Factors associated with one-year mortality were male gender, not performing thrombolysis, sICH, and higher frailty status. Conclusion: Almost 60% of studied patients had very poor outcome. Frailty significantly increases the likelihood of very poor outcome and death after EVT-treated stroke.(c) 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
  • Kaesmacher, Johannes; Abdullayev, Nuran; Maamari, Basel; Dobrocky, Tomas; Vynckier, Jan; Piechowiak, Eike; Pop, Raoul; Behme, Daniel; Sporns, Peter B.; Styczen, Hanna; Virtanen, Pekka; Meyer, Lukas; Meinel, Thomas R.; Cantre, Daniel; Kabbasch, Christoph; Maus, Volker; Pekkola, Johanna; Fischer, Sebastian; Hasiu, Anca; Schwarz, Alexander; Wildgruber, Moritz; Seiffge, David J.; Langner, Soenke; Martinez-Majander, Nicolas; Radbruch, Alexander; Schlamann, Marc; Mihoc, Dan; Beaujeux, Remy; Strbian, Daniel; Fiehler, Jens; Mordasini, Pasquale; Gralla, Jan; Fischer, Urs (2021)
    Background and Purpose Data on safety and efficacy of intra-arterial (IA) fibrinolytics as adjunct to mechanical thrombectomy (MT) are sparse. Methods INtra-arterial FIbriNolytics In ThrombectomY (INFINITY) is a retrospective multi-center observational registry of consecutive patients with anterior circulation large-vessel occlusion ischemic stroke treated with MT and adjunctive administration of IA fibrinolytics (alteplase [tissue plasminogen activator, tPA] or urokinase [UK]) at 10 European centers. Primary outcome was the occurrence of symptomatic intracranial hemorrhage (sICH) according to the European Cooperative Acute Stroke Study II definition. Secondary outcomes were mortality and modified Rankin Scale (mRS) scores at 3 months. Results Of 5,612 patients screened, 311 (median age, 74 years; 44.1% female) received additional IA after or during MT (194 MT+IA tPA, 117 MT+IA UK). IA fibrinolytics were mostly administered for rescue of thrombolysis in cerebral infarction (TICI) 0-2b after MT (80.4%, 250/311). sICH occurred in 27 of 308 patients (8.8%), with an increased risk in patients with initial TICI0/1 (adjusted odds ratio [aOR], 2.3; 95% confidence interval [CI], 1.1 to 5.0 per TICI grade decrease) or in those with intracranial internal carotid artery occlusions (aOR, 3.7; 95% CI, 1.2 to 12.5). In patients with attempted rescue of TICI0-2b and available angiographic follow-up, 116 of 228 patients (50.9%) showed any angiographic reperfusion improvement after IA fibrinolytics, which was associated with mRS Conclusions Administration of IA fibrinolytics as adjunct to MT is performed rarely, but can improve reperfusion, which is associated with better outcomes. Despite a selection bias, an increased risk of sICH seems possible, which underlines the importance of careful patient selection.
  • Lindsberg, Perttu J.; Kantanen, Anne-Mari; Mattila, Olli S.; Soinne, Lauri; Puolakka, Tuukka; Jäkälä, Pekka; Lappalainen, Kimmo; Kuisma, Markku (2017)